Remission definitions guiding immunosuppressive therapy in rheumatoid arthritis: which is best fitted for the purpose?

Remission definitions guiding immunosuppressive therapy in rheumatoid arthritis: which is best fitted for the purpose?

Objective To assess which definition of remission best predicts good radiographic outcome (GRO) and good functional outcome (GFO) in rheumatoid arthritis, focusing the updated American College of Rheumatology/European Alliance of Associations for Rheumatology criteria.Material and methods Meta-analy...

Full description

Bibliographic Details
Main Authors:	Désirée van der Heijde, Laure Gossec, Pedro M Machado, Johannes W G Jacobs, Paco M J Welsing, José António Pereira Da Silva, Ricardo J O Ferreira, Cátia Duarte
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2024-02-01
Series:	RMD Open
Online Access:	https://rmdopen.bmj.com/content/10/1/e003972.full

Similar Items

Correspondence on “Re‐examining remission definitions in rheumatoid arthritis: considering the 28‐Joint Disease Activity Score, C‐reactive protein level and patient global assessment” by Felson et al
by: Ricardo J. O. Ferreira, et al.
Published: (2022-03-01)

Ultrasound remission in patients with rheumatoid arthritis in clinical remission
by: Rym Fakhfakh, et al.
Published: (2021-12-01)

Active rheumatoid arthritis with multiple pulmonary nodules failure to multiple remissive therapy: Which is the solution?
by: Ileana Cosmina Filipescu, et al.
Published: (2021-09-01)

Overtreatment in rheumatoid arthritis: are there reasons for concern?
by: Laure Gossec, et al.
Published: (2022-10-01)

Considerations for the definition of remission criteria in psoriatic arthritis
by: Mease, P, et al.
Published: (2017)

What is the best target in a treat-to-target strategy in rheumatoid arthritis? Results from a systematic review and meta-regression analysis
by: Daniel Aletaha, et al.
Published: (2023-04-01)

RHEUMATOID ARTHRITIS: THE PROBLEMS OF REMISSION AND THERAPY RESISTANCE
by: E. L. Nasonov, et al.
Published: (2018-07-01)

Patient’s perspective of sustained remission in rheumatoid arthritis
by: Irazú Contreras-Yáñez, et al.
Published: (2017-09-01)

Prevalence and predictors for sustained remission in rheumatoid arthritis.
by: Yoon-Kyoung Sung, et al.
Published: (2019-01-01)

Association between obesity and likelihood of remission or low disease activity status in psoriatic arthritis applying index-based and patient-based definitions of remission: a cross-sectional study
by: Laure Gossec, et al.
Published: (2023-07-01)

Seeking allergy when it hides: which are the best fitting tests?
by: Cristoforo Incorvaia, et al.
Published: (2013-01-01)

Late-onset rheumatoid arthritis has a similar time to remission as younger-onset rheumatoid arthritis: results from the Ontario Best Practices Research Initiative
by: Xiuying Li, et al.
Published: (2022-11-01)

Concomitant prednisone may alleviate methotrexate side-effects in rheumatoid arthritis patients
by: Matthijs S. van der Leeuw, et al.
Published: (2023-05-01)

Robust analyses for radiographic progression in rheumatoid arthritis
by: Robert Landewé, et al.
Published: (2023-04-01)

Variants of intensification of immunosuppressive therapy of rheumatoid arthritis
by: E A Vasiljeva, et al.
Published: (2007-04-01)

Immunosuppressive treatment and the risk of diabetes in rheumatoid arthritis.
by: Siri Lillegraven, et al.
Published: (2019-01-01)

Predictors of Remission in Rheumatoid Arthritis Patients Treated with Biologics:
by: Yasmin Khader
Published: (2023-05-01)

CLINICAL AND ULTRASOUND ANKLE INVOLVEMENT IN RHEUMATOID ARTHRITIS IN REMISSION
by: Luminita Enache, et al.
Published: (2019-06-01)

Correction: Prevalence and predictors for sustained remission in rheumatoid arthritis.
by: Yoon-Kyoung Sung, et al.
Published: (2019-01-01)

Which Curve Fits Best: Fitting ROC Curve Models to Empirical Credit-Scoring Data
by: Błażej Kochański
Published: (2022-09-01)

Is the current ASAS expert definition of a positive family history useful in identifying axial spondyloarthritis? Results from the SPACE and DESIR cohorts
by: Zineb Ez-Zaitouni, et al.
Published: (2017-05-01)

Cancer risks in rheumatoid arthritis patients who received immunosuppressive therapies: Will immunosuppressants work?
by: Yuzhuo Zhang, et al.
Published: (2022-12-01)

Reexamining Remission Definitions in Rheumatoid Arthritis: Considering Disease Activity Score in 28 Joints, C‐Reactive Protein, and Patient Global Assessment
by: David T. Felson, et al.
Published: (2022-02-01)

Association between obesity and likelihood of remission or low disease activity status in psoriatic arthritis applying index-based and patient-based definitions of remission: a cross-sectional study
by: Leung, Y-Y, et al.
Published: (2023)

Proteomic Approaches to Defining Remission and the Risk of Relapse in Rheumatoid Arthritis
by: Liam J. O’Neil, et al.
Published: (2021-11-01)

Intensive therapy and remissions in rheumatoid arthritis: a systematic review
by: Catherine D. Hughes, et al.
Published: (2018-10-01)

Ultrasonographic findings of rheumatoid arthritis patients who are in clinical remission
by: Hadi Karimzadeh, et al.
Published: (2018-01-01)

Sialic-Acid-Related Enzymes of B Cells and Monocytes as Novel Markers to Discriminate Improvement Categories and to Fulfill Two Remission Definitions in Rheumatoid Arthritis
by: Lieh-Bang Liou, et al.
Published: (2023-08-01)

Predicting Remission Among Patients With Rheumatoid Arthritis Starting Tocilizumab Monotherapy: Model Derivation and Remission Score Development
by: Collins, Jamie E., et al.
Published: (2021)

The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis
by: Yoshiya Tanaka, et al.
Published: (2019-07-01)

Predicting Remission Among Patients With Rheumatoid Arthritis Starting Tocilizumab Monotherapy: Model Derivation and Remission Score Development
by: Jamie E. Collins, et al.
Published: (2020-02-01)

Best practices for the development and fit-for-purpose validation of biomarker methods: a conference report
by: Joel Mathews, et al.
Published: (2022-02-01)

The PRINTO provisional definition of remission in juvenile dermatomyositis
by: Kasapcopur O, et al.
Published: (2011-09-01)

STRATEGY FOR DOSE REDUCTION AND DISCONTINUATION OF BIOLOGICAL AGENTS IN RHEUMATOID ARTHRITIS REMISSION
by: M. A. Kotovskaya, et al.
Published: (2018-03-01)

ADALIMUMAB DISCONTINUATION IN PATIENTS WITH RHEUMATOID ARTHRITIS AFTER ACHIEVING SUSTAINED REMISSION
by: N. V. Demidova, et al.
Published: (2018-07-01)

Low activity and remission in rheumatoid arthritis. Clinical, immunological and morphological aspects
by: D E Karateev
Published: (2009-10-01)

Early rheumatoid arthritis: a prospective study on how to induce the remission
by: S. Zingarelli, et al.
Published: (2011-09-01)

Baseline predictors of remission, pain and fatigue in rheumatoid arthritis: the TITRATE trial
by: Sook Yan Lee, et al.
Published: (2021-11-01)

Selective immunosuppression of tumour necrosis factor-alpha in rheumatoid arthritis.
by: Brennan, F, et al.
Published: (1995)

The GP tests of competence assessment: which part best predicts fitness to practise decisions?
by: Hirosha Keshani Jayaweera, et al.
Published: (2018-01-01)